Sato, Y., Watanabe, H., Sone, M., Onaya, H., Sakamoto, N., Osuga, K., . . . Arai, Y. (2013). Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602. Informa Healthcare.
Stile di citazione ChicagoSato, Yozo, Hirokazu Watanabe, Miyuki Sone, Hiroaki Onaya, Noriaki Sakamoto, Keigo Osuga, Masahide Takahashi, e Yasuaki Arai. Tumor Response Evaluation Criteria for HCC (hepatocellular Carcinoma) Treated Using TACE (transcatheter Arterial Chemoembolization): RECIST (response Evaluation Criteria in Solid Tumors) Version 1.1 and MRECIST (modified RECIST): JIVROSG-0602. Informa Healthcare, 2013.
Citazione MLASato, Yozo, et al. Tumor Response Evaluation Criteria for HCC (hepatocellular Carcinoma) Treated Using TACE (transcatheter Arterial Chemoembolization): RECIST (response Evaluation Criteria in Solid Tumors) Version 1.1 and MRECIST (modified RECIST): JIVROSG-0602. Informa Healthcare, 2013.